Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Franklin Resources, Inc. (BEN) vs Quest Diagnostics Inc (DGX) Price & Performance

Franklin Resources, Inc.Trade
Quest Diagnostics IncTrade

Price performance (Past 24H)

Key statistics

Franklin Resources, Inc. vs Quest Diagnostics Inc — how do they compare? Franklin Resources, Inc. trades at $33.37 (market cap $16.95B), while Quest Diagnostics Inc trades at $237.5 (market cap $26.21B). The key difference: Quest Diagnostics Inc is the larger of the two by market cap, and Franklin Resources, Inc. pays the higher dividend (3.96%). Which is the better fit depends on your goals.

BENDGX
Market Cap
$16.95B$26.21B
Sector
FinancialsHealth
52-Week High
$35.77$238.50
52-Week Low
$21.18$173.49
Enterprise Value
$29.90B$31.97B
Dividend Yield
3.96%1.45%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Franklin Resources, Inc.

Franklin Resources provides investment services for individual and institutional investors. At the end of August 2022, Franklin had $1.388 trillion in managed assets, composed primarily of equity (32%), fixed-income (38%), multi-asset/balanced (10%) funds, alternatives (16%), and money market funds (4%). Distribution tends to be weighted more toward retail investors (49% of AUM) investors, as opposed to institutional (49%) and high-net-worth (2%) clients. Franklin is also one of the more global firms of the U.S.-based asset managers with more than 35% of its AUM invested in global/international strategies and 25% of managed assets sourced from clients domiciled outside the United States.

Read more on BEN

About Quest Diagnostics Inc

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.

Read more on DGX